Nivolumab (Nivo) plus ipilimumab (Ipi) 6-month treatment versus continuation in patients with advanced non-small-cell-lung cancer (aNSCLC): 3-year results of the IFCT-1701 DICIPLE phase 3 trial
Journal article published in 2023 by
Gerard Zalcman 
,
Anne Madroszyk,
Charles Dayen,
Olivier Molinier,
Thomas Egenod,
Didier Debieuvre,
Sophie Beaucaire-Danel,
Adrien Dixmier,
Eric Pichon,
Sigole Ne Galland-Girodet,
Etienne Giroux Leprieur,
Nicolas Cloarec,
Jacques Cadranel,
Josiane Otto,
Nicolas Pote
and other authors.
,
Anne Madroszyk,
Charles Dayen,
Olivier Molinier,
Thomas Egenod,
Didier Debieuvre,
Sophie Beaucaire-Danel,
Adrien Dixmier,
Eric Pichon,
Sigole Ne Galland-Girodet,
Etienne Giroux Leprieur,
Nicolas Cloarec,
Jacques Cadranel,
Josiane Otto,
Nicolas Pote
and other authors.
